In patients with polymyalgia rheumatica receiving glucocorticoids, bisphosphonate prescribing was linked to a slight reduction in fracture risk, while gastroprotective medications were not associated ...
Preemptive azacitidine treatment guided by measurable residual disease (MRD) status was associated with delayed relapse in patients with myelodysplastic neoplasms or acute myeloid leukemia (AML), with ...